J. Fruchart

New England Journal of Medicine · 2000–2020

A researcher in the Science corpus: 11 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom J. Fruchart trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Andrew C. Li

Papers from J. Fruchart's perspective

Ordered by how strongly the researchers J. Fruchart trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Cardiovascular morbidity and mortality associated with the metabolic syndrome. (Diabetes Care)
  2. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (Journal of the American Medical Association (JAMA))
  3. Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice
  4. Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome (Proceedings of the National Academy of Sciences of the United States of America)
  5. Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus (Circulation)
  6. Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ (Science)
  7. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. (Genes & Development)
  8. Roles of PPARs in health and disease (Nature)
  9. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase (Nature)
  10. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. (Proceedings of the National Academy of Sciences of the United States of America)

Their papers